Compare · SYRA vs VRSK
SYRA vs VRSK
Side-by-side comparison of Syra Health Corp. (SYRA) and Verisk Analytics Inc. (VRSK): market cap, price performance, sector, and recent activity on the wire.
Summary
- SYRA operates in Consumer Discretionary, while VRSK operates in Industrials - the two are in different parts of the market.
- VRSK carries a market cap of $26.38B.
- Over the past year, SYRA is up 0.0% and VRSK is down 31.5% - SYRA leads by 31.5 points.
- VRSK has been more active in the news (8 items in the past 4 weeks vs 2 for SYRA).
- VRSK has more recent analyst coverage (25 ratings vs 0 for SYRA).
- Company
- Syra Health Corp.
- Verisk Analytics Inc.
- Price
- $0.18+42.31%
- $201.36+4.24%
- Market cap
- -
- $26.38B
- 1M return
- +0.00%
- +11.87%
- 1Y return
- +0.00%
- -31.54%
- Industry
- Diversified Commercial Services
- Diversified Commercial Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2009
- News (4w)
- 2
- 8
- Recent ratings
- 0
- 25
Verisk Analytics Inc.
Verisk Analytics, Inc. provides data analytics solutions in the United States and internationally. It provides predictive analytics and decision support solutions to customers in rating, underwriting, claims, catastrophe and weather risk, global risk analytics, natural resources intelligence, economic forecasting, commercial banking and finance, and various other fields. The company operates through three segments: Insurance, Energy and Specialized Markets, and Financial Services. The Insurance segment focuses on the prediction of loss, selection and pricing of risk, and compliance with their reporting requirements for property and casualty customers. It also develops machine learned and artificially intelligent models to forecast scenarios and produce standard and customized analytics that help its customers to manage their businesses, including detecting fraud before and after a loss event, and quantifying losses. The Energy and Specialized Markets segment provides data analytics for the natural resources value chain, including energy, chemicals, metals, mining, power, and renewables sectors; research and consulting services focusing on exploration strategies and screening, asset development and acquisition, commodity markets, and corporate analysis; and consultancy services in the areas of business environment, business improvement, business strategies, commercial advisory, and transaction support, as well as analysis and advice on assets, companies, governments, and markets. The Financial Services segment offers benchmarking, decisioning algorithms, business intelligence, and customized analytic services to financial institutions, payment networks and processors, alternative lenders, regulators, and merchants. The company was founded in 1971 and is headquartered in Jersey City, New Jersey.
Latest SYRA
- Syra Health Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy
- SEC Form DEFA14A filed by Syra Health Corp.
- SEC Form DEF 14A filed by Syra Health Corp.
- SEC Form 10-Q filed by Syra Health Corp.
- Syra Health Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
- Syra Health To Announce First Quarter 2026 Financial Results
- Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards
- Amendment: SEC Form 10-K/A filed by Syra Health Corp.
Latest VRSK
- Verisk Analytics upgraded by Jefferies with a new price target
- Chief Financial Officer Mann Elizabeth sold $76,844 worth of shares (400 units at $192.11) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 18,784 units (SEC Form 4)
- Director Purtill Sabra R. was granted 163 shares, increasing direct ownership by 6% to 3,092 units (SEC Form 4)
- Director Perry Christopher John was granted 146 shares, increasing direct ownership by 3% to 4,625 units (SEC Form 4)
- Director Hendrick Gregory was granted 146 shares, increasing direct ownership by 3% to 4,737 units (SEC Form 4)
- Director Patiath Pradip was granted 69 shares, increasing direct ownership by 5% to 1,421 units (SEC Form 4)
- Director Liss Samuel G was granted 167 shares, increasing direct ownership by 0.24% to 69,265 units (SEC Form 4)
- Verisk to Announce Fiscal Second-Quarter 2026 Results on July 29, 2026
- Verisk Estimates Economic Losses From June 24 Venezuela Earthquake Sequence Will Exceed USD 10 Billion
- U.S. P&C Insurers Post Strong 92.4 Combined Ratio as Premium Growth Slows Sharply